226 related articles for article (PubMed ID: 34230168)
1. The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in Gastric Cancer.
Hyun CL; Park SJ; Kim HS; Song HJ; Kim HU; Lee C; Lee DH; Maeng YH; Kim YS; Jang B
Anticancer Res; 2021 Jul; 41(7):3689-3698. PubMed ID: 34230168
[TBL] [Abstract][Full Text] [Related]
2. SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers.
Jang BG; Kim HS; Bae JM; Kim WH; Kim HU; Kang GH
Sci Rep; 2020 Sep; 10(1):14591. PubMed ID: 32884102
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
Jang BG; Lee BL; Kim WH
Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
[TBL] [Abstract][Full Text] [Related]
4. Expression profile of intestinal stem cell and cancer stem cell markers in gastric cancers with submucosal invasion.
Kim HS; Song HJ; Kim HU; Jeong IH; Koh HM; Shin JH; Jang BG
Pathol Res Pract; 2021 Feb; 218():153336. PubMed ID: 33450435
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of SMOC2 expression in papillary thyroid carcinoma and its prognostic significance.
Kim HS; Choi JH; Lee JY; Kang J; Myung JK; Kim WH; Jang BG
Sci Rep; 2020 Mar; 10(1):4853. PubMed ID: 32184420
[TBL] [Abstract][Full Text] [Related]
6. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
[TBL] [Abstract][Full Text] [Related]
7. Sequential expression of putative stem cell markers in gastric carcinogenesis.
Wang T; Ong CW; Shi J; Srivastava S; Yan B; Cheng CL; Yong WP; Chan SL; Yeoh KG; Iacopetta B; Salto-Tellez M
Br J Cancer; 2011 Aug; 105(5):658-65. PubMed ID: 21829201
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin receptor expression in gastric carcinoma: implications in tumor development and progression.
Shin E; Park DJ; Kim HH; Won NH; Choe G; Lee HS
J Cancer Res Clin Oncol; 2013 Apr; 139(4):709-18. PubMed ID: 23358721
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.
Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM
Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490
[TBL] [Abstract][Full Text] [Related]
10. Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer.
Jang BG; Lee BL; Kim WH
Virchows Arch; 2015 Sep; 467(3):285-94. PubMed ID: 26070873
[TBL] [Abstract][Full Text] [Related]
11. Intestinal Stem Cell Markers in the Intestinal Metaplasia of Stomach and Barrett's Esophagus.
Jang BG; Lee BL; Kim WH
PLoS One; 2015; 10(5):e0127300. PubMed ID: 25996368
[TBL] [Abstract][Full Text] [Related]
12. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
13. Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers.
Kim TM; Ko YH; Ha SJ; Lee HH
BMC Cancer; 2019 Feb; 19(1):119. PubMed ID: 30717708
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa.
Mizoshita T; Tsukamoto T; Inada K; Ogasawara N; Hirata A; Kato S; Joh T; Itoh M; Yamamura Y; Tatematsu M
Pathol Int; 2004 Jun; 54(6):392-400. PubMed ID: 15144397
[TBL] [Abstract][Full Text] [Related]
15. EPHB2 expression is associated with intestinal phenotype of gastric cancer and indicates better prognosis by suppressing gastric cancer migration.
Kim H; Myung JK; Paik SS; Kim H; Park H; Kim YJ; Lee SB; Kim HU; Song HJ; Jeong IH; Hong S; Park CM; Lee C; Kim Y; Jang B
Am J Cancer Res; 2022; 12(3):1295-1308. PubMed ID: 35411225
[TBL] [Abstract][Full Text] [Related]
16. Expression and significance of Musashi-1 in gastric cancer and precancerous lesions.
Kuang RG; Kuang Y; Luo QF; Zhou CJ; Ji R; Wang JW
World J Gastroenterol; 2013 Oct; 19(39):6637-44. PubMed ID: 24151393
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved.
Lu L; Wu M; Sun L; Li W; Fu W; Zhang X; Liu T
Medicine (Baltimore); 2016 Oct; 95(42):e5163. PubMed ID: 27759647
[TBL] [Abstract][Full Text] [Related]
18. Cancerous and non-neoplastic stem cells in the stomach similarly express CD44 and CD133.
Feitosa NPP; Pereira VBM; Silva BGB; Queroz AVF; Rodrigues BJ; Costa MLV; Alencar CH; Lima-Júnior RCP; Wong DVT; Frota CC; Almeida PRC
Acta Histochem; 2021 Oct; 123(7):151787. PubMed ID: 34517259
[TBL] [Abstract][Full Text] [Related]
19. CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: Prognostic implications.
Seno H; Oshima M; Taniguchi MA; Usami K; Ishikawa TO; Chiba T; Taketo MM
Int J Oncol; 2002 Oct; 21(4):769-74. PubMed ID: 12239615
[TBL] [Abstract][Full Text] [Related]
20. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
